NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA3 | hg19_v2_chr10_+_8096769_8096787 | -0.51 | 3.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_27998689 | 3.03 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr14_+_91709103 | 2.64 |
ENST00000553725.1
|
CTD-2547L24.3
|
HCG1816139; Uncharacterized protein |
chr1_-_153113927 | 2.54 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr2_+_228678550 | 2.46 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr17_+_38171681 | 2.22 |
ENST00000225474.2
ENST00000331769.2 ENST00000394148.3 ENST00000577675.1 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr14_+_94577074 | 2.19 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr5_+_131409476 | 2.07 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr1_-_153066998 | 1.97 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr1_-_153013588 | 1.62 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr11_-_18270182 | 1.50 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
chr4_+_74606223 | 1.48 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr17_-_4689649 | 1.46 |
ENST00000441199.2
ENST00000416307.2 |
VMO1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr15_+_42565393 | 1.43 |
ENST00000561871.1
|
GANC
|
glucosidase, alpha; neutral C |
chr6_+_26251835 | 1.42 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
chr19_+_10654854 | 1.38 |
ENST00000586477.1
ENST00000586863.1 |
ATG4D
|
autophagy related 4D, cysteine peptidase |
chr2_-_113999260 | 1.37 |
ENST00000468980.2
|
PAX8
|
paired box 8 |
chr1_+_153330322 | 1.35 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr17_+_38171614 | 1.34 |
ENST00000583218.1
ENST00000394149.3 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr11_-_105010320 | 1.32 |
ENST00000532895.1
ENST00000530950.1 |
CARD18
|
caspase recruitment domain family, member 18 |
chr19_-_41903161 | 1.27 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr2_+_89952792 | 1.22 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr2_+_113735575 | 1.12 |
ENST00000376489.2
ENST00000259205.4 |
IL36G
|
interleukin 36, gamma |
chr1_+_79086088 | 1.08 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr1_-_153044083 | 1.07 |
ENST00000341611.2
|
SPRR2B
|
small proline-rich protein 2B |
chr18_+_39739223 | 1.07 |
ENST00000601948.1
|
LINC00907
|
long intergenic non-protein coding RNA 907 |
chr1_+_37947257 | 0.99 |
ENST00000471012.1
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr10_+_44101850 | 0.95 |
ENST00000361807.3
ENST00000374437.2 ENST00000430885.1 ENST00000374435.3 |
ZNF485
|
zinc finger protein 485 |
chr1_-_153029980 | 0.92 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr22_-_30866564 | 0.91 |
ENST00000435069.1
ENST00000415957.2 ENST00000540910.1 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
chr7_+_22766766 | 0.89 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr2_-_241835561 | 0.88 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr6_+_32006159 | 0.86 |
ENST00000478281.1
ENST00000471671.1 ENST00000435122.2 |
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr15_-_55488817 | 0.85 |
ENST00000569386.1
|
RSL24D1
|
ribosomal L24 domain containing 1 |
chr7_+_106415457 | 0.85 |
ENST00000490162.2
ENST00000470135.1 |
RP5-884M6.1
|
RP5-884M6.1 |
chr19_+_46531127 | 0.85 |
ENST00000601033.1
|
CTC-344H19.4
|
CTC-344H19.4 |
chr19_-_54604083 | 0.85 |
ENST00000391761.1
ENST00000356532.3 ENST00000359649.4 ENST00000358375.4 ENST00000391760.1 ENST00000351806.4 |
OSCAR
|
osteoclast associated, immunoglobulin-like receptor |
chr3_+_177545563 | 0.84 |
ENST00000434309.1
|
RP11-91K9.1
|
RP11-91K9.1 |
chr6_+_32812568 | 0.82 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr6_-_160166218 | 0.81 |
ENST00000537657.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr2_+_47799601 | 0.81 |
ENST00000601243.1
|
AC138655.1
|
CDNA: FLJ23120 fis, clone LNG07989; HCG1987724; Uncharacterized protein |
chr6_-_133055815 | 0.80 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr6_+_4773205 | 0.80 |
ENST00000440139.1
|
CDYL
|
chromodomain protein, Y-like |
chr5_-_150466692 | 0.80 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr5_-_119669160 | 0.80 |
ENST00000514240.1
|
CTC-552D5.1
|
CTC-552D5.1 |
chr11_+_18154059 | 0.80 |
ENST00000531264.1
|
MRGPRX3
|
MAS-related GPR, member X3 |
chr12_+_113344582 | 0.79 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr7_+_143771275 | 0.79 |
ENST00000408898.2
|
OR2A25
|
olfactory receptor, family 2, subfamily A, member 25 |
chr2_-_241396131 | 0.79 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr17_-_4689727 | 0.79 |
ENST00000328739.5
ENST00000354194.4 |
VMO1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr5_-_150467221 | 0.77 |
ENST00000522226.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr6_+_33043703 | 0.76 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr12_+_7167980 | 0.76 |
ENST00000360817.5
ENST00000402681.3 |
C1S
|
complement component 1, s subcomponent |
chr2_-_214017151 | 0.76 |
ENST00000452786.1
|
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr5_-_141338627 | 0.76 |
ENST00000231484.3
|
PCDH12
|
protocadherin 12 |
chr14_+_103592636 | 0.75 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr6_+_80714332 | 0.75 |
ENST00000502580.1
ENST00000511260.1 |
TTK
|
TTK protein kinase |
chr19_+_50180409 | 0.75 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
chr8_+_55467072 | 0.75 |
ENST00000602362.1
|
RP11-53M11.3
|
RP11-53M11.3 |
chr20_+_44637526 | 0.74 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr2_-_208030295 | 0.74 |
ENST00000458272.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr1_+_153004800 | 0.74 |
ENST00000392661.3
|
SPRR1B
|
small proline-rich protein 1B |
chr6_+_27775899 | 0.74 |
ENST00000358739.3
|
HIST1H2AI
|
histone cluster 1, H2ai |
chr4_+_76481258 | 0.74 |
ENST00000311623.4
ENST00000435974.2 |
C4orf26
|
chromosome 4 open reading frame 26 |
chr3_-_4793274 | 0.73 |
ENST00000414938.1
|
EGOT
|
eosinophil granule ontogeny transcript (non-protein coding) |
chr10_-_102289611 | 0.72 |
ENST00000299166.4
ENST00000370320.4 ENST00000531258.1 ENST00000370322.1 ENST00000535773.1 |
NDUFB8
SEC31B
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa SEC31 homolog B (S. cerevisiae) |
chr17_-_4843316 | 0.72 |
ENST00000544061.2
|
SLC25A11
|
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 |
chr15_-_80263506 | 0.71 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr20_-_62203808 | 0.71 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr17_-_42994283 | 0.70 |
ENST00000593179.1
|
GFAP
|
glial fibrillary acidic protein |
chr6_-_29527702 | 0.70 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr1_+_948803 | 0.70 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr5_-_146461027 | 0.70 |
ENST00000394410.2
ENST00000508267.1 ENST00000504198.1 |
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr12_+_113344811 | 0.70 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr6_-_26250835 | 0.69 |
ENST00000446824.2
|
HIST1H3F
|
histone cluster 1, H3f |
chr5_-_180235755 | 0.69 |
ENST00000502678.1
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr12_+_42624050 | 0.69 |
ENST00000601185.1
|
AC020629.1
|
Uncharacterized protein |
chr6_+_31515337 | 0.69 |
ENST00000376148.4
ENST00000376145.4 |
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
chr20_+_31823792 | 0.69 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
chr2_-_241396106 | 0.68 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr20_-_43883197 | 0.67 |
ENST00000338380.2
|
SLPI
|
secretory leukocyte peptidase inhibitor |
chr11_+_33563618 | 0.67 |
ENST00000526400.1
|
KIAA1549L
|
KIAA1549-like |
chr10_-_4285835 | 0.66 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr19_+_39574945 | 0.66 |
ENST00000331256.5
|
PAPL
|
Iron/zinc purple acid phosphatase-like protein |
chr19_-_42931567 | 0.66 |
ENST00000244289.4
|
LIPE
|
lipase, hormone-sensitive |
chr17_+_7253667 | 0.66 |
ENST00000570504.1
ENST00000574499.1 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_+_45140400 | 0.65 |
ENST00000453711.1
|
C1orf228
|
chromosome 1 open reading frame 228 |
chr19_-_51466681 | 0.65 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr3_+_121289551 | 0.65 |
ENST00000334384.3
|
ARGFX
|
arginine-fifty homeobox |
chr19_-_10946949 | 0.65 |
ENST00000214869.2
ENST00000591695.1 |
TMED1
|
transmembrane emp24 protein transport domain containing 1 |
chr19_+_35596873 | 0.65 |
ENST00000313865.6
|
AC020907.1
|
Uncharacterized protein |
chr13_-_46742630 | 0.65 |
ENST00000416500.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr19_+_57999079 | 0.65 |
ENST00000426954.2
ENST00000354197.4 ENST00000523882.1 ENST00000520540.1 ENST00000519310.1 ENST00000442920.2 ENST00000523312.1 ENST00000424930.2 |
ZNF419
|
zinc finger protein 419 |
chr19_+_57999101 | 0.65 |
ENST00000347466.6
ENST00000523138.1 ENST00000415379.2 ENST00000521754.1 ENST00000221735.7 ENST00000518999.1 ENST00000521137.1 |
ZNF419
|
zinc finger protein 419 |
chr5_+_43033818 | 0.65 |
ENST00000607830.1
|
CTD-2035E11.4
|
CTD-2035E11.4 |
chr17_-_6616678 | 0.64 |
ENST00000381074.4
ENST00000293800.6 ENST00000572352.1 ENST00000576323.1 ENST00000573648.1 |
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr17_+_7533439 | 0.64 |
ENST00000441599.2
ENST00000380450.4 ENST00000416273.3 ENST00000575903.1 ENST00000576830.1 ENST00000571153.1 ENST00000575618.1 ENST00000576152.1 |
SHBG
|
sex hormone-binding globulin |
chr4_-_74864386 | 0.64 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr3_+_52454971 | 0.63 |
ENST00000465863.1
|
PHF7
|
PHD finger protein 7 |
chr17_+_45908974 | 0.63 |
ENST00000269025.4
|
LRRC46
|
leucine rich repeat containing 46 |
chr11_+_118272328 | 0.63 |
ENST00000524422.1
|
ATP5L
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G |
chr14_+_55221541 | 0.63 |
ENST00000555192.1
|
SAMD4A
|
sterile alpha motif domain containing 4A |
chr16_+_67694849 | 0.63 |
ENST00000602551.1
ENST00000458121.2 ENST00000219255.3 |
PARD6A
|
par-6 family cell polarity regulator alpha |
chr16_+_31483451 | 0.62 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr6_+_43968306 | 0.62 |
ENST00000442114.2
ENST00000336600.5 ENST00000439969.2 |
C6orf223
|
chromosome 6 open reading frame 223 |
chr2_-_113594279 | 0.62 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr1_-_152779104 | 0.62 |
ENST00000606576.1
ENST00000368768.1 |
LCE1C
|
late cornified envelope 1C |
chr15_-_72668805 | 0.62 |
ENST00000268097.5
|
HEXA
|
hexosaminidase A (alpha polypeptide) |
chr4_-_140201333 | 0.61 |
ENST00000398955.1
|
MGARP
|
mitochondria-localized glutamic acid-rich protein |
chr1_+_153003671 | 0.61 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr17_-_38859996 | 0.61 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
chr12_+_113354341 | 0.61 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr10_+_81892477 | 0.60 |
ENST00000372263.3
|
PLAC9
|
placenta-specific 9 |
chr16_-_55867146 | 0.60 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr6_+_31543334 | 0.60 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
chr16_-_75467274 | 0.59 |
ENST00000566254.1
|
CFDP1
|
craniofacial development protein 1 |
chrM_+_4431 | 0.59 |
ENST00000361453.3
|
MT-ND2
|
mitochondrially encoded NADH dehydrogenase 2 |
chr1_-_153085984 | 0.59 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chr6_+_13182751 | 0.58 |
ENST00000415087.1
|
PHACTR1
|
phosphatase and actin regulator 1 |
chr5_-_150473127 | 0.58 |
ENST00000521001.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr11_+_73675873 | 0.58 |
ENST00000537753.1
ENST00000542350.1 |
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
chr19_+_15218180 | 0.58 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr19_-_55740632 | 0.58 |
ENST00000327042.4
|
TMEM86B
|
transmembrane protein 86B |
chr1_+_152486950 | 0.57 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
chr16_-_3137080 | 0.57 |
ENST00000574387.1
ENST00000571404.1 |
RP11-473M20.9
|
RP11-473M20.9 |
chr5_-_141338377 | 0.56 |
ENST00000510041.1
|
PCDH12
|
protocadherin 12 |
chr10_-_46342675 | 0.56 |
ENST00000492347.1
|
AGAP4
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 |
chr5_+_159895275 | 0.56 |
ENST00000517927.1
|
MIR146A
|
microRNA 146a |
chr19_+_29704142 | 0.56 |
ENST00000587859.1
ENST00000590607.1 |
CTB-32O4.2
|
CTB-32O4.2 |
chr11_+_66115304 | 0.55 |
ENST00000531602.1
|
RP11-867G23.8
|
Uncharacterized protein |
chr19_-_10227503 | 0.55 |
ENST00000593054.1
|
EIF3G
|
eukaryotic translation initiation factor 3, subunit G |
chr14_-_88200641 | 0.55 |
ENST00000556168.1
|
RP11-1152H15.1
|
RP11-1152H15.1 |
chr8_-_42065187 | 0.55 |
ENST00000270189.6
ENST00000352041.3 ENST00000220809.4 |
PLAT
|
plasminogen activator, tissue |
chr17_-_7760457 | 0.55 |
ENST00000576384.1
|
LSMD1
|
LSM domain containing 1 |
chr9_+_97562440 | 0.54 |
ENST00000395357.2
|
C9orf3
|
chromosome 9 open reading frame 3 |
chr14_-_81425828 | 0.54 |
ENST00000555529.1
ENST00000556042.1 ENST00000556981.1 |
CEP128
|
centrosomal protein 128kDa |
chr16_+_56672571 | 0.54 |
ENST00000290705.8
|
MT1A
|
metallothionein 1A |
chr19_+_7743387 | 0.54 |
ENST00000597959.1
|
CTD-3214H19.16
|
CTD-3214H19.16 |
chr12_+_96337061 | 0.54 |
ENST00000266736.2
|
AMDHD1
|
amidohydrolase domain containing 1 |
chr13_-_24471194 | 0.54 |
ENST00000382137.3
ENST00000382057.3 |
C1QTNF9B
|
C1q and tumor necrosis factor related protein 9B |
chr2_-_61389168 | 0.54 |
ENST00000607743.1
ENST00000605902.1 |
RP11-493E12.1
|
RP11-493E12.1 |
chr8_-_65730127 | 0.54 |
ENST00000522106.1
|
RP11-1D12.2
|
RP11-1D12.2 |
chr8_-_42065075 | 0.53 |
ENST00000429089.2
ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT
|
plasminogen activator, tissue |
chr17_+_41158742 | 0.53 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr19_-_30199516 | 0.53 |
ENST00000591243.1
|
C19orf12
|
chromosome 19 open reading frame 12 |
chr18_+_61564389 | 0.53 |
ENST00000397996.2
ENST00000418725.1 |
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
chr11_+_64685026 | 0.53 |
ENST00000526559.1
|
PPP2R5B
|
protein phosphatase 2, regulatory subunit B', beta |
chr7_+_74188309 | 0.53 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr16_-_28503080 | 0.53 |
ENST00000565316.1
ENST00000565778.1 ENST00000357857.9 ENST00000568558.1 ENST00000357806.7 |
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr3_+_75713481 | 0.53 |
ENST00000308062.3
ENST00000464571.1 |
FRG2C
|
FSHD region gene 2 family, member C |
chr5_-_159766528 | 0.53 |
ENST00000505287.2
|
CCNJL
|
cyclin J-like |
chr6_-_133055896 | 0.52 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
chr15_-_42076229 | 0.52 |
ENST00000597767.1
|
AC073657.1
|
Uncharacterized protein |
chr16_+_30007524 | 0.52 |
ENST00000567254.1
ENST00000567705.1 |
INO80E
|
INO80 complex subunit E |
chr17_-_56591321 | 0.52 |
ENST00000583243.1
|
MTMR4
|
myotubularin related protein 4 |
chr3_-_142720267 | 0.52 |
ENST00000597953.1
|
RP11-91G21.1
|
RP11-91G21.1 |
chr16_+_2079501 | 0.52 |
ENST00000563587.1
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
chr17_-_79792909 | 0.52 |
ENST00000330261.4
ENST00000570394.1 |
PPP1R27
|
protein phosphatase 1, regulatory subunit 27 |
chr2_+_62132800 | 0.52 |
ENST00000538736.1
|
COMMD1
|
copper metabolism (Murr1) domain containing 1 |
chr1_-_144866711 | 0.52 |
ENST00000530130.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr16_+_47496023 | 0.51 |
ENST00000567200.1
|
PHKB
|
phosphorylase kinase, beta |
chr19_-_49955050 | 0.51 |
ENST00000262265.5
|
PIH1D1
|
PIH1 domain containing 1 |
chr19_+_17830051 | 0.51 |
ENST00000594625.1
ENST00000324096.4 ENST00000600186.1 ENST00000597735.1 |
MAP1S
|
microtubule-associated protein 1S |
chr19_-_6690723 | 0.51 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr5_-_135290705 | 0.51 |
ENST00000274507.1
|
LECT2
|
leukocyte cell-derived chemotaxin 2 |
chr15_+_101402041 | 0.51 |
ENST00000558475.1
ENST00000558641.1 ENST00000559673.1 |
RP11-66B24.1
|
RP11-66B24.1 |
chr16_-_28503357 | 0.51 |
ENST00000333496.9
ENST00000561505.1 ENST00000567963.1 ENST00000354630.5 ENST00000355477.5 ENST00000357076.5 ENST00000565688.1 ENST00000359984.7 |
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr14_-_50506589 | 0.50 |
ENST00000553914.2
|
RP11-58E21.3
|
RP11-58E21.3 |
chr17_+_4843413 | 0.50 |
ENST00000572430.1
ENST00000262482.6 |
RNF167
|
ring finger protein 167 |
chr12_-_11508520 | 0.50 |
ENST00000545626.1
ENST00000500254.2 |
PRB1
|
proline-rich protein BstNI subfamily 1 |
chr1_-_153123345 | 0.50 |
ENST00000368748.4
|
SPRR2G
|
small proline-rich protein 2G |
chr15_+_45722727 | 0.49 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
chr17_-_4710288 | 0.49 |
ENST00000571067.1
|
RP11-81A22.5
|
RP11-81A22.5 |
chr19_+_37837218 | 0.49 |
ENST00000591134.1
|
HKR1
|
HKR1, GLI-Kruppel zinc finger family member |
chr3_-_126194707 | 0.49 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
chr14_-_24729251 | 0.49 |
ENST00000559136.1
|
TGM1
|
transglutaminase 1 |
chr20_-_44516256 | 0.49 |
ENST00000372519.3
|
SPATA25
|
spermatogenesis associated 25 |
chrX_+_69488174 | 0.49 |
ENST00000480877.2
ENST00000307959.8 |
ARR3
|
arrestin 3, retinal (X-arrestin) |
chr7_-_139756791 | 0.49 |
ENST00000489809.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr15_-_60695071 | 0.49 |
ENST00000557904.1
|
ANXA2
|
annexin A2 |
chr14_-_89960395 | 0.48 |
ENST00000555034.1
ENST00000553904.1 |
FOXN3
|
forkhead box N3 |
chr11_+_117073850 | 0.48 |
ENST00000529622.1
|
TAGLN
|
transgelin |
chr11_-_61647935 | 0.48 |
ENST00000531956.1
|
FADS3
|
fatty acid desaturase 3 |
chr16_+_55512742 | 0.48 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr1_-_89738528 | 0.48 |
ENST00000343435.5
|
GBP5
|
guanylate binding protein 5 |
chr5_-_139726181 | 0.48 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr16_+_30194916 | 0.48 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr9_-_21368075 | 0.48 |
ENST00000449498.1
|
IFNA13
|
interferon, alpha 13 |
chr15_+_42066888 | 0.48 |
ENST00000510535.1
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1 |
chr20_-_35329063 | 0.48 |
ENST00000422536.1
|
NDRG3
|
NDRG family member 3 |
chr19_-_18314799 | 0.48 |
ENST00000481914.2
|
RAB3A
|
RAB3A, member RAS oncogene family |
chr19_+_40854559 | 0.47 |
ENST00000598962.1
ENST00000409419.1 ENST00000409587.1 ENST00000602131.1 ENST00000409735.4 ENST00000600948.1 ENST00000356508.5 ENST00000596682.1 ENST00000594908.1 |
PLD3
|
phospholipase D family, member 3 |
chr7_-_1067968 | 0.47 |
ENST00000412051.1
|
C7orf50
|
chromosome 7 open reading frame 50 |
chr4_-_171011084 | 0.47 |
ENST00000337664.4
|
AADAT
|
aminoadipate aminotransferase |
chr8_-_22549856 | 0.47 |
ENST00000522910.1
|
EGR3
|
early growth response 3 |
chr12_-_7245125 | 0.47 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr19_+_50180507 | 0.47 |
ENST00000454376.2
ENST00000524771.1 |
PRMT1
|
protein arginine methyltransferase 1 |
chr2_+_62132781 | 0.47 |
ENST00000311832.5
|
COMMD1
|
copper metabolism (Murr1) domain containing 1 |
chr10_-_112255945 | 0.47 |
ENST00000609514.1
ENST00000607952.1 |
RP11-525A16.4
|
RP11-525A16.4 |
chrM_+_10758 | 0.47 |
ENST00000361381.2
|
MT-ND4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr6_+_27791862 | 0.47 |
ENST00000355057.1
|
HIST1H4J
|
histone cluster 1, H4j |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.7 | 2.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 1.4 | GO:1901147 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.5 | 1.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 2.2 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.0 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.3 | 1.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.9 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.3 | 3.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 1.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.3 | 3.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.9 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.3 | 1.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 1.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 1.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 1.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.8 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.2 | 0.9 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.2 | 0.9 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 0.7 | GO:0039521 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.2 | 0.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.2 | 0.6 | GO:1990768 | positive regulation of growth rate(GO:0040010) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.2 | 1.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.2 | 0.2 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 0.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.4 | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
0.2 | 0.8 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.2 | 1.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 13.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.7 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.2 | 0.5 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 1.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.2 | GO:0071450 | response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:1903947 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.5 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
0.1 | 0.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.3 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.1 | 0.4 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.1 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.4 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.1 | 0.3 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.9 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.5 | GO:0052229 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 0.5 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.1 | 0.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.1 | 0.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.6 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.5 | GO:0070945 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.1 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.3 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.3 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 1.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.3 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
0.1 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.5 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.3 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 0.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 1.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 1.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.5 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 1.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.3 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.1 | 0.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.5 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 1.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.4 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.1 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.4 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0032903 | viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.3 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.3 | GO:2001226 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
0.1 | 0.3 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.4 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 0.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.5 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:1904301 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.1 | 0.5 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.3 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.4 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.1 | 0.2 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 0.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.6 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 0.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 1.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.4 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.1 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0002775 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.1 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 1.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.1 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.3 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.3 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.1 | 0.2 | GO:0043060 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.1 | 3.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.4 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.2 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 0.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.1 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.1 | 0.4 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.1 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.3 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.4 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.1 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 2.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 1.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0043132 | NAD transport(GO:0043132) |
0.1 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.1 | 0.5 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.1 | GO:0009204 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) deoxyribonucleoside triphosphate catabolic process(GO:0009204) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 1.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.3 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.3 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.1 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.1 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.1 | 0.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.3 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 6.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 1.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.0 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 1.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
0.0 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.0 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 3.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.3 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.0 | 0.4 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.0 | 0.2 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
0.0 | 0.2 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.0 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 1.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.3 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 1.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:1902824 | cleavage furrow ingression(GO:0036090) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.0 | 0.2 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.0 | 0.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.2 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.0 | 0.1 | GO:0006140 | regulation of nucleotide metabolic process(GO:0006140) |
0.0 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.0 | 0.1 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.6 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.2 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.0 | 0.2 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.0 | 1.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006816 | calcium ion transport(GO:0006816) |
0.0 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.8 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.3 | GO:0035787 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.0 | 1.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0008406 | gonad development(GO:0008406) development of primary sexual characteristics(GO:0045137) |
0.0 | 0.2 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.0 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0060482 | lung goblet cell differentiation(GO:0060480) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.0 | 1.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.4 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.0 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.6 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.0 | 0.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.0 | GO:1903800 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.3 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.0 | 0.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.2 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.1 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.0 | 0.1 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.0 | 0.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.0 | 0.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.0 | 0.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.8 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.0 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.2 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 2.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.0 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.4 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.0 | 0.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:0021551 | central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
0.0 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.0 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.0 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.0 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.0 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.0 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.6 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.2 | GO:0071362 | cellular response to ether(GO:0071362) |
0.0 | 0.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 0.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.2 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.0 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.7 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.0 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.0 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.0 | GO:0061564 | axon development(GO:0061564) |
0.0 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.0 | 0.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.0 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.0 | 0.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.0 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.0 | 0.0 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.0 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.1 | GO:2000116 | regulation of cysteine-type endopeptidase activity(GO:2000116) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:1904956 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.0 | 0.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.0 | 0.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.0 | 0.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.0 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.0 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.0 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.1 | GO:0098759 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.1 | GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) |
0.0 | 0.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.0 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
0.0 | 0.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.0 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.0 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.1 | GO:0052041 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.0 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
0.0 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.6 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 2.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 1.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 1.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 1.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 1.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 0.6 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0005715 | late recombination nodule(GO:0005715) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 0.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.1 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.0 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 1.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.0 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.4 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 1.5 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 1.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 3.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.0 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.0 | 2.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 1.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.8 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 3.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.0 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.6 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.0 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 2.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.3 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.5 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.0 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 1.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.0 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 4.2 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.4 | 1.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 1.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 1.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 1.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 1.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.7 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 0.7 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.2 | 0.6 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
0.2 | 1.9 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 1.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.7 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.2 | 0.5 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.2 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.6 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 0.7 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.5 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 1.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.9 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.4 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.1 | 0.3 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.3 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.1 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.5 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.1 | 0.3 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.6 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.3 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.2 | GO:0031177 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.2 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.1 | 1.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0030545 | receptor regulator activity(GO:0030545) |
0.1 | 0.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.1 | 3.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.1 | 0.2 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.1 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.2 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.3 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.2 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.3 | GO:0099583 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 1.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.0 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 3.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.0 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.0 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.1 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 0.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.0 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0009881 | G-protein coupled photoreceptor activity(GO:0008020) photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 2.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.7 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.0 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.0 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0015227 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) acyl carnitine transmembrane transporter activity(GO:0015227) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.3 | GO:0030228 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.4 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0008513 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.0 | GO:0072545 | tyrosine binding(GO:0072545) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 3.6 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.0 | 0.1 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 5.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.1 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.0 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 1.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.0 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.0 | 0.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.0 | 2.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.0 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.0 | 3.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 1.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.0 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 3.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 2.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 9.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 2.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 11.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 5.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 3.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 2.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 2.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 2.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 1.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 2.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.7 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 1.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |